⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,839.73
−0.20%
FTSE ADX
9,848.74
+0.67%
TASI
9,970.57
−1.51%
QE Index
8,650.34
+0.20%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,961.44
+0.00%
DFM:EMIRATESNBD
AED 31.46
−0.13%
ADX:IHC
AED 359.90
+2.24%
SAU:2222
SAR 25.60
−0.78%
DSMD:QNBK
QAR 15.45
−1.34%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 302.00
+0.85%
Gold
$4,121.77
−0.46%
Brent
$111.17
+1.79%
BTC
$81,454.75
−0.47%
ETH
$2,384.56
−0.86%
DFM General
5,839.73
−0.20%
FTSE ADX
9,848.74
+0.67%
TASI
9,970.57
−1.51%
QE Index
8,650.34
+0.20%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,961.44
+0.00%
DFM:EMIRATESNBD
AED 31.46
−0.13%
ADX:IHC
AED 359.90
+2.24%
SAU:2222
SAR 25.60
−0.78%
DSMD:QNBK
QAR 15.45
−1.34%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 302.00
+0.85%
Gold
$4,121.77
−0.46%
Brent
$111.17
+1.79%
BTC
$81,454.75
−0.47%
ETH
$2,384.56
−0.86%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Open
🇸🇦
Saudi Arabia
Tadawul · TASI
Open
🇶🇦
Qatar
QSE · QE General
Open
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Open
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Regeneron Pharmaceuticals Inc · News · TradingHolo
Markets
›
United States
› NAS
› REGN
R
Regeneron Pharmaceuticals Inc
NAS:REGN
Healthcare
CBOE:SPESG
NASDAQ:NBI
$782.04
−1.10%
At close
At close · Tue 20 Oct · ≈
AED 2,872.04
· Market cap
$80.51B
· Next earnings
Wed 28 Oct
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
REGN news
Headlines tagged to this company
DO
Regeneron Pharma Is Maintained at Overweight by Piper Sandler
Dow Jones Newswires · 16 h ago
SE
Regeneron-backed Parabilis rises ahead of trial data for lead asset
Seeking Alpha · 17 h ago
RE
Major drugmakers turn to China for licensing deals
Reuters · 19 h ago
SE
EyePoint plunges after late-stage trial setback for lead drug against Eylea
Seeking Alpha · 20 h ago
RE
EyePoint to halve workforce after experimental drug fails second late-stage trial
Reuters · 21 h ago
RE
EyePoint to cut workforce by half after experimental drug fails second late-stage trial
Reuters · 21 h ago
DO
Regeneron Gets CHMP Backing for Reduced Libtayo Dosing Schedule
Dow Jones Newswires · 4 d ago
DP
Regeneron's Libtayo Wins EMA CHMP Support For Extended Dosing
dpa-AFX · 4 d ago
TR
Regeneron Pharmaceuticals, Inc. (REGN) Wins CHMP Backing For Libtayo q6w Dosing
TradingView · 4 d ago
DO
Regeneron Pharma Price Target Raised to $978.00/Share From $660.00 by UBS
Dow Jones Newswires · 4 d ago
DO
Why Healthcare Stocks Are Hot When the AI Trade Runs Cold — Barrons.com
Dow Jones Newswires · 5 d ago
SE
Regeneron a new Buy at UBS as Street undervalues Dupixent's future
Seeking Alpha · 5 d ago
ST
Regeneron’s Rare Disease Drug Shows Zero New Abnormal Bone Growth In Extended Trial – REGN Stock Heads For Best Day In Over A Month
Stocktwits · 8 d ago
RE
Regeneron Pharmaceuticals Says Pasatru Shows Sustained Efficacy & Consistent Safety Profile From Weeks 56 To 84
Reuters · 8 d ago
GL
Pasatru™ (garetosmab-grts) Demonstrates Zero New Heterotopic Ossification (HO) Lesions in Adult Fibrodysplasia Ossificans Progressiva (FOP) Patients During OPTIMA Trial Extension
GlobeNewswire · 8 d ago
DO
Regeneron Pharma Is Maintained at Sector Perform by RBC Capital
Dow Jones Newswires · 12 d ago
DO
Regeneron Pharma Price Target Raised to $780.00/Share From $772.00 by Truist Securities
Dow Jones Newswires · 13 d ago
DO
Regeneron Pharma Price Target Raised to $779.00/Share From $758.00 by Morgan Stanley
Dow Jones Newswires · 13 d ago
DO
Regeneron Pharma Price Target Raised to $950.00/Share From $900.00 by JP Morgan
Dow Jones Newswires · 14 d ago
SE
Regeneron sees nearly $0.18 per share earnings headwind after Sanofi deal
Seeking Alpha · 14 d ago
More news →